Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
NAD+
EfficacyHigh
Studies8
Participants572
StatusAvailable

NAD+

Nicotinamide Adenine Dinucleotide

NAD+ is a vital coenzyme present in every cell that plays crucial roles in energy metabolism, DNA repair, and cellular aging processes. As NAD+ levels naturally decline with age (by ~50% by age 50), supplementation through IV therapy or injections aims to restore cellular energy production, activate longevity pathways through sirtuin proteins, and support mitochondrial health. Research demonstrates significant improvements in cognitive function, physical performance, and biomarkers of aging.

Clinical Safety Profile

Reported Side Effects

Mild nausea or stomach discomfort (especially IV)
Flushing or warm sensation during administration
Fatigue or drowsiness post-treatment (temporary)
Injection site reactions (subcutaneous)
Headache (rare, usually mild)
Dizziness during IV infusion
Muscle cramping (rare)
Anxiety or jitteriness (dose-dependent)

Side Effect Management (Clinical Trial Data)

Nausea
Common
22.5%
Flushing
Common
18.3%
Fatigue
Occasional
12.7%
Headache
Infrequent
8.4%
Injection Site Reaction
Common
15.2%
Dizziness
Infrequent
6.1%
Muscleaches
Infrequent
4.8%

Side Effect Management Strategies

Nausea: Take with food, smaller meals, ginger supplements
Vomiting: Slower dose escalation, anti-emetics if severe
Diarrhea: Adequate hydration, probiotics, bland diet
Constipation: Increase fiber intake, adequate fluids, light exercise

Clinical Safety Metrics

Variable
Overall Safety Rating
Variable
Discontinuation Rate
Research
Approved Status

CONTRAINDICATIONS

• Active cancer diagnosis (theoretical growth promotion concern)
• Severe kidney or liver disease
• Pregnancy and breastfeeding (insufficient safety data)
• Known hypersensitivity to NAD+ or injection components

Medical Disclaimer

NAD+ therapy is currently in research phase and not FDA-approved for specific medical conditions. This information is for educational purposes and should not replace consultation with qualified healthcare providers. Individual results may vary significantly. Professional medical supervision is recommended for all NAD+ therapeutic protocols.